Clinical Trials Logo

NSAID Associated Gastric Ulcers clinical trials

View clinical trials related to NSAID Associated Gastric Ulcers.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT00633672 Completed - Clinical trials for NSAID Associated Gastric Ulcers

A Comparative Efficacy and Safety Study of Nexium Delayed-Release Capsules (40mg qd and 20mg qd) Versus Ranitidine 150mg Bid for the Healing of NSAID-Associated Gastric Ulcers When Daily NSAID Use is Continued

Start date: February 2001
Phase: Phase 3
Study type: Interventional

Nonsteroidal anti-inflammatory drugs (NSAIDS) are often associated with gastric ulcers. This study looks at the treatment of these gastric ulcers with one of the three following treatment groups: esomeprazole 40 mg once daily; esomeprazole 20 mg once daily; or ranitidine 150 mg twice daily.

NCT ID: NCT00633412 Completed - Clinical trials for NSAID Associated Gastric Ulcers

A Comparative Efficacy and Safety Study of Nexium Delayed-Release Capsules (40mg qd and 20mg qd) Versus Ranitidine 150mg Bid for the Healing of NSAID-Associated Gastric Ulcers When Daily NSAID Use is Continued in Subjects in the US Only

Start date: February 2001
Phase: Phase 3
Study type: Interventional

Nonsteroidal anti-inflammatory drugs (NSAIDS) are often associated with gastric ulcers. This study looks at the treatment of these gastric ulcers with one of the three following treatment groups for up to 8 weeks: esomeprazole 40 mg once daily; esomeprazole 20 mg once daily; or ranitidine 150 mg twice daily for subjects in the US only.

NCT ID: NCT00629928 Completed - Clinical trials for NSAID Associated Gastric Ulcers

Ulcer Prevention II

Start date: February 2001
Phase: Phase 3
Study type: Interventional

Nonsteroidal anti-inflammatory drugs (NSAIDS) are often associated with gastric ulcers. This study looks at the prevention of these gastric ulcers, in patients deemed to be at risk, with either esomeprazole 40 mg once daily; esomeprazole 20 mg once daily.

NCT ID: NCT00629512 Completed - Clinical trials for NSAID Associated Gastric Ulcers

Prevention of Gastric Ulcers

Start date: March 2001
Phase: Phase 3
Study type: Interventional

Nonsteroidal anti-inflammatory drugs (NSAIDS) are often associated with gastric ulcers. This study looks at the prevention of these gastric ulcers with one of the three following treatment groups for up to 8 weeks: esomeprazole 40 mg once daily; esomeprazole 20 mg once daily; versus placebo; in patients at risk.